Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Ohashi

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 24, 2013
Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patientsJunichi Fukada, Naoyuki Shigematsu, Hiroya Takeuchi, et al.
Cancer Medicine|March 27, 2018
Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancerShuichi Nishimura, Toshio Ohashi, Tetsuo Momma, et al.
The Keio Journal of Medicine|October 26, 2025
Palliative Radiotherapy for Colorectal Villous Adenoma with Severe Diarrhea and Electrolyte ImbalanceHirofumi Toyama, Yoshihiro Nakazato, Yuka Katsurada, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2015
Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapyShinya Sutani, Toshio Ohashi, Masanori Sakayori, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapyAtsuya Takeda, Etsuo Kunieda, Naoko Sanuki, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2012
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancerAtsuya Takeda, Etsuo Kunieda, Hirofumi Fujii, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|May 11, 2019
Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)Nobumichi Tanaka, Atsunori Yorozu, Takashi Kikuchi, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|August 24, 2013
Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patientsJunichi Fukada, Naoyuki Shigematsu, Hiroya Takeuchi, et al.
Cancer Medicine|March 27, 2018
Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancerShuichi Nishimura, Toshio Ohashi, Tetsuo Momma, et al.
The Keio Journal of Medicine|October 26, 2025
Palliative Radiotherapy for Colorectal Villous Adenoma with Severe Diarrhea and Electrolyte ImbalanceHirofumi Toyama, Yoshihiro Nakazato, Yuka Katsurada, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2015
Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapyShinya Sutani, Toshio Ohashi, Masanori Sakayori, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapyAtsuya Takeda, Etsuo Kunieda, Naoko Sanuki, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2012
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancerAtsuya Takeda, Etsuo Kunieda, Hirofumi Fujii, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|May 11, 2019
Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)Nobumichi Tanaka, Atsunori Yorozu, Takashi Kikuchi, et al.
Pageof 9